Cidara Therapeutics, Inc. (CDTX) DCF Valuation

Cidara Therapeutics, Inc. (CDTX) DCF Valuation
  • ✓ Entièrement Modifiable: Adapté À Vos Besoins Dans Excel Ou Sheets
  • ✓ Conception Professionnelle: Modèles Fiables Et Conformes Aux Normes Du Secteur
  • ✓ Pré-Construits Pour Une Utilisation Rapide Et Efficace
  • ✓ Aucune Expertise N'Est Requise; Facile À Suivre

Cidara Therapeutics, Inc. (CDTX) Bundle

DCF model
Get Full Bundle:
$25 $15
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7

TOTAL:

Gain insights into your Cidara Therapeutics, Inc. (CDTX) valuation analysis using our sophisticated DCF Calculator! This Excel template comes preloaded with accurate (CDTX) data, enabling you to adjust forecasts and assumptions to determine Cidara's intrinsic value with precision.


Discounted Cash Flow (DCF) - (USD MM)

Year AY1
2019		 AY2
2020		 AY3
2021		 AY4
2022		 AY5
2023		 FY1
2024		 FY2
2025		 FY3
2026		 FY4
2027		 FY5
2028
Revenue 20.9 12.1 49.6 64.3 63.9 77.8 94.6 115.2 140.2 170.6
Revenue Growth, % 0 -42.3 310.81 29.69 -0.59576 21.7 21.7 21.7 21.7 21.7
EBITDA -41.4 -71.6 -42.3 -33.4 -24.4 -58.4 -71.0 -86.4 -105.2 -128.0
EBITDA, % -197.92 -593.05 -85.24 -51.89 -38.13 -75.05 -75.05 -75.05 -75.05 -75.05
Depreciation .3 .3 .2 .1 .1 .7 .9 1.1 1.3 1.6
Depreciation, % 1.57 2.37 0.38126 0.22244 0.18465 0.94534 0.94534 0.94534 0.94534 0.94534
EBIT -41.7 -71.8 -42.4 -33.5 -24.5 -58.5 -71.2 -86.6 -105.4 -128.3
EBIT, % -199.49 -595.42 -85.62 -52.11 -38.31 -75.21 -75.21 -75.21 -75.21 -75.21
Total Cash 60.3 35.9 62.3 32.7 35.8 63.3 77.0 93.7 114.1 138.8
Total Cash, percent .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Account Receivables .0 11.2 5.4 5.8 16.2
Account Receivables, % 0.04781257 92.61 10.8 9.07 25.42
Inventories -5.5 .0 -2.6 .0 6.1 -3.5 -4.2 -5.1 -6.2 -7.6
Inventories, % -26.52 0 -5.23 0.0000015555 9.54 -4.44 -4.44 -4.44 -4.44 -4.44
Accounts Payable 1.9 4.6 1.3 1.4 3.8 9.0 10.9 13.3 16.2 19.7
Accounts Payable, % 9.02 37.86 2.62 2.25 5.9 11.53 11.53 11.53 11.53 11.53
Capital Expenditure .0 -.2 .0 -.1 -.5 -.4 -.5 -.6 -.8 -.9
Capital Expenditure, % -0.16734 -1.54 -0.08270798 -0.18355 -0.79024 -0.55305 -0.55305 -0.55305 -0.55305 -0.55305
Tax Rate, % -1.97 -1.97 -1.97 -1.97 -1.97 -1.97 -1.97 -1.97 -1.97 -1.97
EBITAT -40.7 -72.1 -43.9 -33.8 -25.0 -58.2 -70.8 -86.2 -104.9 -127.7
Depreciation
Changes in Account Receivables
Changes in Inventories
Changes in Accounts Payable
Capital Expenditure
UFCF -33.0 -86.0 -38.6 -36.7 -39.5 -48.4 -72.4 -88.1 -107.3 -130.5
WACC, % 8.93 8.93 8.93 8.93 8.93 8.93 8.93 8.93 8.93 8.93
PV UFCF
SUM PV UFCF -334.9
Long Term Growth Rate, % 2.00
Free cash flow (T + 1) -133
Terminal Value -1,921
Present Terminal Value -1,253
Enterprise Value -1,588
Net Debt -31
Equity Value -1,557
Diluted Shares Outstanding, MM 4
Equity Value Per Share -356.12

What You Will Receive

  • Comprehensive Financial Model: Cidara Therapeutics' (CDTX) actual data facilitates accurate DCF valuation.
  • Complete Forecast Flexibility: Modify revenue growth, profit margins, WACC, and other essential metrics.
  • Real-Time Calculations: Instant updates allow you to view results immediately as adjustments are made.
  • Professional-Grade Template: A polished Excel file crafted for high-quality valuation presentations.
  • Adaptable and Reusable: Designed for versatility, enabling repeated application for in-depth forecasts.

Key Features

  • Comprehensive Data: Cidara Therapeutics, Inc.'s (CDTX) historical financial statements and pre-filled projections.
  • Customizable Parameters: Adjust WACC, tax rates, revenue growth, and EBITDA margins as needed.
  • Real-Time Insights: Observe Cidara's intrinsic value update instantly.
  • Intuitive Visuals: Dashboard graphs illustrate valuation outcomes and essential metrics.
  • Designed for Precision: A reliable tool for analysts, investors, and finance professionals.

How It Works

  • Download: Obtain the pre-formatted Excel file containing Cidara Therapeutics, Inc. (CDTX) financial data.
  • Customize: Modify projections, such as revenue growth, EBITDA %, and WACC.
  • Update Automatically: The intrinsic value and NPV calculations refresh in real-time.
  • Test Scenarios: Generate various forecasts and evaluate results instantly.
  • Make Decisions: Leverage the valuation insights to inform your investment choices.

Why Choose This Calculator for Cidara Therapeutics, Inc. (CDTX)?

  • User-Friendly Interface: Tailored for both novice and experienced users.
  • Customizable Inputs: Modify assumptions easily to suit your financial analysis.
  • Real-Time Valuation: Observe immediate updates to Cidara's valuation as you tweak inputs.
  • Preloaded Data: Comes with Cidara's actual financial information for swift evaluations.
  • Relied Upon by Experts: Utilized by investors and analysts for making well-informed choices.

Who Should Use This Product?

  • Individual Investors: Make informed decisions regarding the buying or selling of Cidara Therapeutics, Inc. (CDTX) stock.
  • Financial Analysts: Enhance valuation processes with comprehensive financial models tailored for Cidara Therapeutics, Inc. (CDTX).
  • Consultants: Provide clients with expert valuation insights on Cidara Therapeutics, Inc. (CDTX) swiftly and accurately.
  • Business Owners: Gain insights into how biotech companies like Cidara Therapeutics, Inc. (CDTX) are valued to inform your own business strategies.
  • Finance Students: Study valuation techniques using real-world data and scenarios related to Cidara Therapeutics, Inc. (CDTX).

What the Template Contains

  • Pre-Filled DCF Model: Cidara Therapeutics, Inc.'s (CDTX) financial data preloaded for immediate use.
  • WACC Calculator: Detailed calculations for Weighted Average Cost of Capital.
  • Financial Ratios: Evaluate Cidara's profitability, leverage, and efficiency.
  • Editable Inputs: Change assumptions such as growth, margins, and CAPEX to fit your scenarios.
  • Financial Statements: Annual and quarterly reports to support detailed analysis.
  • Interactive Dashboard: Easily visualize key valuation metrics and results.

No products were found matching.